Address
Email address
Phone number
https://innomedica.eeInnomedica | Ravi- ja uuringukeskusInnomedica | Ravi- ja uuringukeskus. Meie arstikeskuse kogenud arstide poole võib pöörduda kõigi terviseprobleemidega. Vaata lisaks
Name
OÜ INNOMEDICA
Registry code
11832212
VAT number
EE101371447
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
22.12.2009 (14)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86221 - Provision of specialised medical treatment
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Sandra Meisalu 21.04.1985 (39) | 30% - 766.00 EUR | Board member | Direct ownership | |
| Helen Tälli 24.01.1974 (50) | 70% - 1 790.00 EUR | Board member | Direct ownership | Founder |
| Jaak Tälli 08.02.1959 (65) | - | Board member | - |
| 2019 14.07.2020 | 2020 18.06.2021 | 2021 01.07.2022 | 2022 05.07.2023 | |
|---|---|---|---|---|
| Total Revenue | 482 272 € | 427 770 € | 572 998 € | 665 558 € |
| Net profit (loss) for the period | -84 373 € | -76 402 € | 10 766 € | 19 177 € |
| Profit Margin | -17% | -18% | 2% | 3% |
| Current Assets | 523 344 € | 453 703 € | 453 936 € | 462 975 € |
| Fixed Assets | 84 431 € | 73 966 € | 70 683 € | 90 363 € |
| Total Assets | 607 775 € | 527 669 € | 524 619 € | 553 338 € |
| Current Liabilities | 53 551 € | 49 847 € | 36 031 € | 45 573 € |
| Non Current Liabilities | 0 € | 0 € | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 554 224 € | 477 822 € | 488 588 € | 507 765 € |
| Employees | 15 | 12 | 12 | 11 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 119 454 € | 35 735.15 € | 38 420.5 € | 16 |
| 2023 Q4 | 74 606.97 € | 33 712.38 € | 36 279.68 € | 16 |
| 2023 Q3 | 64 091.06 € | 34 464.1 € | 36 368.53 € | 14 |
| 2023 Q2 | 73 942 € | 29 814.8 € | 31 826.02 € | 15 |
| 2023 Q1 | 124 484.2 € | 24 973.09 € | 26 475.53 € | 15 |
| 2022 Q4 | 104 175 € | 22 889.58 € | 24 347.61 € | 12 |
| 2022 Q3 | 55 155.06 € | 22 498.93 € | 23 139.35 € | 11 |
| 2022 Q2 | 75 957.32 € | 20 169.6 € | 21 500.35 € | 11 |
| 2022 Q1 | 161 080.69 € | 20 383.95 € | 20 962.14 € | 11 |
| 2021 Q4 | 137 744.66 € | 21 309.97 € | 22 404.77 € | 11 |
| 2021 Q3 | 74 415 € | 23 986.51 € | 25 815.68 € | 15 |
| 2021 Q2 | 96 582.83 € | 24 808.16 € | 25 644.97 € | 16 |
| 2021 Q1 | 73 789.42 € | 30 192.53 € | 26 632.69 € | 19 |
| 2020 Q4 | 51 910.2 € | 25 528.41 € | 23 075.48 € | 17 |
| 2020 Q3 | 24 347.4 € | 23 557.5 € | 23 335.22 € | 16 |
| 2020 Q2 | 87 344.6 € | 20 268.01 € | 15 363.82 € | 18 |
| 2020 Q1 | 68 377.92 € | 29 301.35 € | 29 666.84 € | 18 |
